Injunction Ordered Against Limiting Medication Abortions in Ohio
UNITED STATES, JUL 8 – Medical groups cite studies showing 11% of women experience serious adverse events from mifepristone and urge FDA to reinstate safety restrictions removed under recent administrations.
- A Cincinnati judge issued a preliminary injunction against restrictions on medication abortions in Ohio, blocking a law that penalizes healthcare providers for these procedures.
- The court's decision allows advanced practice clinicians to provide medication abortions, aligning with the Reproductive Freedom Amendment's protections.
- Judge Alison Hatheway stated that any abortion restrictions must prioritize patient health based on evidence-based standards.
- Planned Parenthood and the ACLU expressed relief over the ruling, reinforcing the need to maintain access to medication abortions in Ohio.
11 Articles
11 Articles
Group gathers signatures for abortion rights
BY MAX SILVERSONThe Star-News About 75 people met in McCall on Tuesday to support a citizen-backed ballot initiative that would restore abortion rights in Idaho.… Login to continue reading Login Sign up for complimentary access Sign Up Now Close
Ohio Preliminary Injunction Allows Advanced Practice Clinicians to Provide Medication Abortions
(CINCINNATI) — On July 8, the Hamilton County Court of Common Pleas granted a third preliminary injunction in a case filed on behalf of abortion clinics and health care providers by the American Civil Liberties Union, the ACLU of Ohio,…
The Fight for Life: Marjorie Dannenfelser — Watch CURE America
Across a nation fractured by abortion, Marjorie Dannenfelser, president of Susan B. Anthony Pro-Life America, sits with host Donald T. Eason on this week’s episode of CURE America to lay bare the stakes of the pro-life cause. As leader of the country’s largest pro-life organization, Dannenfelser pulls back the curtain on chemical abortions, spotlighting a …
Abortion Drugs Injure 11% of Women Who Take Them, HHS Must Take Action
CatholicVote joined a coalition of pro-life organizations in a letter calling on Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. and Food and Drug Administration (FDA) Commissioner Dr. Marty Makary to protect women from the risks associated with the abortion drug mifepristone and reinstate safety restrictions that were loosened under the Biden administration. “The recent revelation of commercial insurance data from 865,727 prescr…
Coverage Details
Bias Distribution
- 89% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium